Form 4: Director Graham Smith Receives Axon Equity Grant
Director Equity Grant Disclosure
Director Graham Smith acquired 611 shares of Axon Enterprise, Inc. common stock via a restricted stock unit grant.
Summary
- Director Graham Smith was granted 611 restricted stock units (RSUs) on May 29, 2026.
- The shares were granted under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan.
- The grant has a zero-dollar acquisition price.
- Following this transaction, the reporting person's total direct beneficial ownership is 3,629 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified; this is a standard equity compensation disclosure.
Risks
- None identified; this is a standard equity compensation disclosure.
Future Outlook
The restricted stock units are scheduled to vest in full on the earlier of the one-year anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.
Comparison to Industry Standards
- The grant follows standard equity compensation structures for S&P 500 and technology sector board members.
- Vesting schedules tied to annual meetings are consistent with industry best practices for director retention.
Stakeholder Impact
- Minimal impact on shareholders; represents standard director compensation.
Next Steps
- Vesting of the 611 restricted stock units on the earlier of May 29, 2027, or the 2027 Annual Meeting of Shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/29/2026 | Date of the restricted stock unit grant transaction. |
| 06/01/2026 | Date of filing for the Form 4. |
Keywords
Axon Enterprise, AXON, Form 4, Insider Trading, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.